MYGN · Myriad Genetics Inc · Investor Relations
$6.63
+0.00 (+0.00%)
At close · Oct 29
Return incl. dividend (before tax)
Q2 2026 earnings call transcript
Market Cap
$634.16M
Shares
95.65M
Volume · Oct 29
414.26K
Avg daily vol (3M)
2.63M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Upcoming events
| Date | Event | Type |
|---|---|---|
| 2026-11-04 00:00 UTC | Q3 Earnings conference call (announced in 8-K) | Earnings call |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-10 | Wells Fargo Healthcare Conference | Conference |
| 2026-08-04 | Myriad Genetics Second Quarter 2026 Financial Earnings | Earnings call |
| 2026-07-30 | Myriad Genetics Second Quarter 2026 Financial Earnings | Earnings call |
| 2026-05-05 | Myriad Genetics First Quarter 2026 Financial Earnings | Earnings call |
| 2026-03-11 | Barclays 28th Annual Global Healthcare Conference | Conference |
| 2026-03-10 | Leerink Partners Global Healthcare Conference | Conference |
| 2026-02-23 | Q4 FY2025 Earnings conference call (announced in 8-K) | Earnings call |
Source: https://investor.myriad.com/
Key facts
CIK
899923
CUSIP
62855J104
13F (30d)
25 filings
25 filers
Visit website
Investor relations